Global Human ALDH2 Gene Polymorphism Detection Kits Market Growth 2026-2032
Description
The global Human ALDH2 Gene Polymorphism Detection Kits market size is predicted to grow from US$ 21.67 million in 2025 to US$ 40.87 million in 2032; it is expected to grow at a CAGR of 9.7% from 2026 to 2032.
ALDH2 stands for acetaldehyde dehydrogenase 2. Humans' understanding of acetaldehyde dehydrogenase (ALDH) stems from the alcohol metabolism pathway. ALDH is a key enzyme in alcohol metabolism. After drinking, ethanol in the body is mainly metabolized in the liver. Alcohol dehydrogenase (ADH) in the liver is responsible for oxidizing ethanol to acetaldehyde. The generated acetaldehyde is further converted into harmless acetic acid under the catalysis of ALDH as a substrate. At present, at least 19 ALDH isoenzymes have been identified, the most common of which are ALDH1-ALDH4. Among them, ALDH2 plays a major role in the oxidation of acetaldehyde.
ALDH2 is a key enzyme in alcohol metabolism in the human body, responsible for converting toxic acetaldehyde, a secondary metabolite of alcohol, into non-toxic acetic acid. ALDH2 gene mutations can reduce the body's ability to detoxify acetaldehyde. At the same time, ALDH2 gene mutations can also lead to a decrease in the body's ability to metabolize nitroglycerin to form nitric oxide (NO), increasing the risk of ineffective nitroglycerin. In addition, ALDH2*2 mutation is also a genetic risk factor for a variety of chronic diseases, such as cardiovascular disease, cancer and late-onset Alzheimer's disease.
The human ALDH2 gene polymorphism detection kit is used to detect the ALDH2 genotype in genomic DNA extracted from the patient's peripheral blood. The test results only represent the test results of the ALDH2 genotype. It can effectively test the alcohol metabolism ability of ALDH2*2 mutation carriers, guide personalized drinking, and evaluate individual nitrate esterase activity to guide the correct use of emergency drug nitroglycerin. In addition, it can also indicate the risk of diseases related to ALDH2 mutations, strengthen disease prevention and guide healthy lifestyles.
United States market for Human ALDH2 Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human ALDH2 Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human ALDH2 Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human ALDH2 Gene Polymorphism Detection Kits players cover Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Wuhan HealthCare Biotechnology, Hangzhou DIAN Biotechnology, Wuhan Hygeianey Bioscience, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Human ALDH2 Gene Polymorphism Detection Kits Industry Forecast” looks at past sales and reviews total world Human ALDH2 Gene Polymorphism Detection Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected Human ALDH2 Gene Polymorphism Detection Kits sales for 2026 through 2032. With Human ALDH2 Gene Polymorphism Detection Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human ALDH2 Gene Polymorphism Detection Kits industry.
This Insight Report provides a comprehensive analysis of the global Human ALDH2 Gene Polymorphism Detection Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human ALDH2 Gene Polymorphism Detection Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human ALDH2 Gene Polymorphism Detection Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human ALDH2 Gene Polymorphism Detection Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human ALDH2 Gene Polymorphism Detection Kits.
This report presents a comprehensive overview, market shares, and growth opportunities of Human ALDH2 Gene Polymorphism Detection Kits market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
PCR Fluorescent Probe Method
PCR Fluorescent Melting Curve Method
Segmentation by Application:
Hospital
Medical Research Institute
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Wuhan HealthCare Biotechnology
Hangzhou DIAN Biotechnology
Wuhan Hygeianey Bioscience
Xi'an Tianlong Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Human ALDH2 Gene Polymorphism Detection Kits market?
What factors are driving Human ALDH2 Gene Polymorphism Detection Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human ALDH2 Gene Polymorphism Detection Kits market opportunities vary by end market size?
How does Human ALDH2 Gene Polymorphism Detection Kits break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
ALDH2 stands for acetaldehyde dehydrogenase 2. Humans' understanding of acetaldehyde dehydrogenase (ALDH) stems from the alcohol metabolism pathway. ALDH is a key enzyme in alcohol metabolism. After drinking, ethanol in the body is mainly metabolized in the liver. Alcohol dehydrogenase (ADH) in the liver is responsible for oxidizing ethanol to acetaldehyde. The generated acetaldehyde is further converted into harmless acetic acid under the catalysis of ALDH as a substrate. At present, at least 19 ALDH isoenzymes have been identified, the most common of which are ALDH1-ALDH4. Among them, ALDH2 plays a major role in the oxidation of acetaldehyde.
ALDH2 is a key enzyme in alcohol metabolism in the human body, responsible for converting toxic acetaldehyde, a secondary metabolite of alcohol, into non-toxic acetic acid. ALDH2 gene mutations can reduce the body's ability to detoxify acetaldehyde. At the same time, ALDH2 gene mutations can also lead to a decrease in the body's ability to metabolize nitroglycerin to form nitric oxide (NO), increasing the risk of ineffective nitroglycerin. In addition, ALDH2*2 mutation is also a genetic risk factor for a variety of chronic diseases, such as cardiovascular disease, cancer and late-onset Alzheimer's disease.
The human ALDH2 gene polymorphism detection kit is used to detect the ALDH2 genotype in genomic DNA extracted from the patient's peripheral blood. The test results only represent the test results of the ALDH2 genotype. It can effectively test the alcohol metabolism ability of ALDH2*2 mutation carriers, guide personalized drinking, and evaluate individual nitrate esterase activity to guide the correct use of emergency drug nitroglycerin. In addition, it can also indicate the risk of diseases related to ALDH2 mutations, strengthen disease prevention and guide healthy lifestyles.
United States market for Human ALDH2 Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human ALDH2 Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human ALDH2 Gene Polymorphism Detection Kits is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human ALDH2 Gene Polymorphism Detection Kits players cover Sansure Biotech, Wuhan Easy Diagnosis Biomedicine, Wuhan HealthCare Biotechnology, Hangzhou DIAN Biotechnology, Wuhan Hygeianey Bioscience, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Human ALDH2 Gene Polymorphism Detection Kits Industry Forecast” looks at past sales and reviews total world Human ALDH2 Gene Polymorphism Detection Kits sales in 2025, providing a comprehensive analysis by region and market sector of projected Human ALDH2 Gene Polymorphism Detection Kits sales for 2026 through 2032. With Human ALDH2 Gene Polymorphism Detection Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human ALDH2 Gene Polymorphism Detection Kits industry.
This Insight Report provides a comprehensive analysis of the global Human ALDH2 Gene Polymorphism Detection Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human ALDH2 Gene Polymorphism Detection Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human ALDH2 Gene Polymorphism Detection Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human ALDH2 Gene Polymorphism Detection Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human ALDH2 Gene Polymorphism Detection Kits.
This report presents a comprehensive overview, market shares, and growth opportunities of Human ALDH2 Gene Polymorphism Detection Kits market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
PCR Fluorescent Probe Method
PCR Fluorescent Melting Curve Method
Segmentation by Application:
Hospital
Medical Research Institute
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sansure Biotech
Wuhan Easy Diagnosis Biomedicine
Wuhan HealthCare Biotechnology
Hangzhou DIAN Biotechnology
Wuhan Hygeianey Bioscience
Xi'an Tianlong Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Human ALDH2 Gene Polymorphism Detection Kits market?
What factors are driving Human ALDH2 Gene Polymorphism Detection Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human ALDH2 Gene Polymorphism Detection Kits market opportunities vary by end market size?
How does Human ALDH2 Gene Polymorphism Detection Kits break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
105 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Human ALDH2 Gene Polymorphism Detection Kits by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Human ALDH2 Gene Polymorphism Detection Kits by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
